VACCINATION SCHEDULE: Birth - 15 months

byBright Zoom •
0
VACCINATION SCHEDULE: Birth - 15 months


2018 AMERICAN GUIDELINES & RECOMMENDATIONS

NO.VACCINESBirth1 MONTH2 MONTHS4 MONTHS6 MONTHS9 MONTHS12 MONTHS16 MOTHS
1.Hepatitis B (HepB)1st dose2nd dose2nd dose3rd dose3rd dose3rd dose3rd dose
2.Rota virus (Rv)1st dose2nd dosesee Abelow
3.DPT (DTap<7rs)1st dose2nd dose3rd dose4th dose
4.Hemophilus influenza  type b (Hib)1st dose2nd dosesee B below3rd or 4th dose3rd or 4th dose
5.Pneumococcal conjugate vaccine (PCV13)1st dose2nd dose3rd dose4th dose4th dose
6.Inactive Poliovirus (IPV<18yrs)1st dose2nd dose3rd dose3rd dose3rd dose3rd dose
7.Influenza (IIV)Annual Vaccination (1 or 2 dose)Annual Vaccination (1 or 2 doses)Annual Vaccination (1 or 2 dose)Annual vaccination (1 or 2 dose)
8.MMRsee Cbelowsee Cbelow1st dose1st dose
9.Varicella (VAR)1st dose1st dose
10.Hepatitis A.2 dose series. see D below
11.Meningococcal (menACWY)see  Ebelowsee Ebelowsee E belowsee E belowsee E belowsee Ebelow
12.DPT   
(Tdap at or above 7 yrs)
13.Human Papilloma Virus
(HPV)
14.Meningococcal B
15.Pneumococcal Polysaccharide (PPSV23)
Note: The above recommendations must be read along with the Footnotes of this schedule below:
(A). Rotavirus vaccines. (minimum age: 6 weeks)
1. Routine vaccination:
  • Rotarix: 2-dose series at 2 and 4 months.
  • RotaTeq: 3-dose series at 2, 4, and 6 months.
    If any dose in the series is either RotaTeq or unknown, default to 3-dose series.
2. Catch-up vaccination:
  • Do not start the series on or after age 15 weeks, 0 days.
  • The maximum age for the final dose is 8 months, 0 days.
(B). Haemophilus influenzae type b (Hib) conjugate vaccines. (minimum age: 6 weeks)
1. Routine vaccination:
  • ActHIB, Hiberix, or Pentacel: 4-dose series at 2, 4, 6, and 12–15 months.
  • PedvaxHIB: 3-dose series at 2, 4, and 12–15 months.
2. Catch–up vaccination:
  • 1st dose at 7–11 months: Give 2nd dose at least 4 weeks later and 3rd (final) dose at 12–15 months or 8 weeks after 2nd dose (whichever is later).
  • 1st dose at 12–14 months: Give 2nd (final) dose at least 8 weeks after 1st dose.
  • 1st dose before 12 months and 2nd dose before 15 months: Give 3rd (final) dose 8 weeks after 2nd dose.
  • 2 doses of PedvaxHIB before 12 months: Give 3rd (final) dose at 12–59 months and at least 8 weeks after 2nd dose.
  • Unvaccinated at 15–59 months: 1 dose.
3. Special situations:
  • Chemotherapy or radiation treatment  at 12-59 months
    Doses given within 14 days of starting therapy or during therapy should be repeated at least 3 months after therapy completion.
    • Unvaccinated or only 1 dose before 12 months: Give 2 doses, 8 weeks apart.
    • 2 or more doses before 12 months: Give 1 dose, at least 8 weeks after previous dose.
  • Hematopoietic stem cell transplant (HSCT)
    3-dose series with doses 4 weeks apart starting 6 to 12 months after successful transplant (regardless of Hib vaccination history).
  • Anatomic or functional asplenia (including sickle cell disease)
    12-59 months
    • Unvaccinated or only 1 dose before 12 months: Give 2 doses, 8 weeks apart.
    • 2 or more doses before 12 months: Give 1 dose, at least 8 weeks after previous dose.
Unimmunized* persons 5 years or older
  • Give 1 dose.
  • Elective splenectomy
    Unimmunized* persons 15 months or older
    • Give 1 dose (preferably at least 14 days before procedure).
  • HIV infection
    12–59 months
    Unimmunized* persons 5–18 years
    • Unvaccinated or only 1 dose before 12 months: Give 2 doses, 8 weeks apart.
    • 2 or more doses before 12 months: Give 1 dose, at least 8 weeks after previous dose.
    • Give 1 dose.
  • Immunoglobulin deficiency, early component complement deficiency
    12–59 months
    • Unvaccinated or only 1 dose before 12 months: Give 2 doses, 8 weeks apart.
    • 2 or more doses before 12 months: Give 1 dose, at least 8 weeks after previous dose.
*Unimmunized = less than routine series (through 14 months) OR no doses (14 months or older)
(C). Measles, mumps, and rubella (MMR) vaccine.(minimum age: 12 months for routine vaccination)
1. Routine vaccination:
  • 2-dose series at 12–15 months and 4–6 years. The 2nd dose may be given as early as 4 weeks after the 1st dose.
2. Catch-up vaccination:
  • Unvaccinated children and adolescents: 2 doses at least 4 weeks apart.
3. International travel:
  • Infants 6–11 months: 1 dose before departure. Revaccinate with 2 doses at 12–15 months (12 months for children in high-risk areas) and 2nd dose as early as 4 weeks later.
  • Unvaccinated children 12 months and older: 2 doses at least 4 weeks apart before departure.
4. Mumps outbreak:
  • Persons ≥12 months who previously received ≤2 doses of mumps-containing vaccine and are identified by public health authorities to be at increased risk during a mumps outbreak should receive a dose of mumps-virus containing vaccine.
(D). Hepatitis A (HepA) vaccine. (minimum age: 12 months)
1. Routine vaccination:
  • 2 doses, separated by 6–18 months, between the 1st and 2nd birthdays. (A series begun before the 2nd birthday should be completed even if the child turns 2 before the 2nd dose is given.)
2. Catch-up vaccination:
  • Anyone 2 years of age or older may receive HepA vaccine if desired. Minimum interval between doses is 6 months.
3. Special populations:
Previously unvaccinated persons who should be vaccinated:
  • Persons traveling to or working in countries with high or intermediate HepA endemicity
  • Men who have sex with men
  • Users of injection and non-injection drugs
  • Persons who work with hepatitis A virus in a research laborato ry or with non-human primates
  • Persons with clotting-factor disorders
  • Persons with chronic liver disease
  • Persons who anticipate close, personal contact (e.g., household or regular babysitting) with an international adoptee during the first 60 days after arrival in the United States from a country with high or intermediate endemicity (administer the 1st dose as soon as the adoption is planned-ideally at least 2 weeks before the adoptee’s arrival)
(E). Serogroup A, C, W, Y meningococcal vaccines. (Minimum age: 2 months [Menveo], 9 months [Menactra].
1. Routine:
  • 2-dose series: 11-12 years and 16 years.
2. Catch-up:
  • Age 13-15 years: 1 dose now and booster at age 16-18 years. Minimum interval 8 weeks.
  • Age 16-18 years: 1 dose.
3. Special populations and situations:
  • Anatomic or functional asplenia,
  • sickle cell disease
  • HIV infection, persistent complement component deficiency (including eculizumab use):
4. Menveo
  • 1st dose at 8 weeks: 4-dose series at 2, 4, 6, and 12 months.
  • 1st dose at 7–23 months: 2 doses (2nd dose at least 12 weeks after the 1st dose and after the 1st birthday).
  • 1st dose at 24 months or older: 2 doses at least 8 weeks apart.
5. Menactra
  • Persistent complement component deficiency:
    • 9–23 months: 2 doses at least 12 weeks apart.
    • 24 months or older: 2 doses at least 8 weeks apart.
  • Anatomic or functional asplenia, sickle cell disease, or HIV infection:
    • 24 months or older: 2 doses at least 8 weeks apart.
    • Menactra must be administered at least 4 weeks after completion of PCV13 series.
Children who travel to or live in countries where meningococcal disease is hyperendemic or epidemic, including countries in the African meningitis belt or during the Hajj, or exposure to an outbreak attributable to a vaccine serogroup:
  • Children <24 months of age:
    • Menveo (2-23 months):
      • 1st dose at 8 weeks: 4-dose series at 2, 4, 6, and 12 months.
      • 1st dose at 7-23 months: 2 doses (2nd dose at least 12 weeks after the 1st dose and after the 1st birthday).
    • Menactra (9-23 months):
      • 2 doses (2nd dose at least 12 weeks after the 1st dose. 2nd dose may be administered as early as 8 weeks after the 1st dose in travelers).
  • Children 2 years or older: 1 dose of Menveo or Menactra.
Tags:

Post a Comment

Previous Post Next Post